一个风景的淋巴状状腺症及其影响和最近的先进治疗方法
Agrima Yadav1, Shikha Yadav1, Aftab Alam1
1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
Recent advances in anti-infective drug discovery
|February 6, 2024
概括
淋巴状丝腺症影响全球超过1.2亿人. 本综述探讨了新的抗菲拉里亚药物开发,涵盖了对抗这种寄生虫疾病的治疗方法和点.
科学领域:
- 寄生虫学的寄生虫学
- 热带医学 热带医学
- 药物发现 药物发现 药物发现
背景情况:
- 淋巴状 (LF) 是一种使人虚弱的寄生虫疾病,影响全球超过1.2亿人,造成严重的健康,社会和经济负担.
- 由蚊子传播的线虫寄生虫 (Wuchereria bancrofti,Brugia timori,Brugia malayi) 引起的,LF影响了特有地区的134亿人.
- 目前的治疗方法包括合成药物 (伊弗梅克丁,多西环素,阿尔本达) 和天然来源,但耐药性和缺乏疫苗需要新的治疗策略.
研究的目的:
- 审查最近在抗菲拉里菌药物研究方面的进展.
- 提供对 filariasis 的概述,其历史背景,以及全球消除计划.
- 讨论当前和新兴的治疗类,药物点和对 filariasis 的临床研究.
主要方法:
- 科学文章的文献综述和世卫组织关于淋巴性 filariasis 的报告.
- 合成和天然化合物的分析具有抗filarial活动.
- 检查药物标和正在进行的新疗法临床试验.
主要成果:
- 该审查涵盖了各种形式的 filariasis,历史控制努力,以及当前的消除计划.
- 它详细介绍了现有的合成和天然治疗剂及其局限性,包括耐药性.
- 突出了关于新药标和 filariasis 治疗有前途的化合物的新兴研究.
结论:
- 由于现有的治疗限制和药物耐药性的风险,开发新的抗药物是至关重要的.
- 对新药的持续研究,包括天然产品衍生化合物,对于有效控制 filariasis 是必不可少的.
- 了解药物点和推进临床研究将有助于克服淋巴状细菌病的全球负担.
相关概念视频
01:23Introduction to Lymphatic and Immune System
Immunity is a crucial biological concept about our body's inherent capacity to prevent infections and diseases. A complex network of cells and tissues collectively known as the immune system facilitates this natural defense mechanism. The immune system plays an integral role in maintaining our health and well-being, shielding us from potential health threats.
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are born...
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are born...
01:16Lymphatic Vessels and Lymph Transport
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular spaces.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular spaces.
01:15Development of the Lymphatic System
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...